Home Equities Score What was behind the sudden rise in the stock price of Creative...

What was behind the sudden rise in the stock price of Creative Medical Technology Holdings (CELZ)?

In the last session, Creative Medical Technology Holdings (OTC – CELZ) opened its trading at 0.0238 and closed at $0.0278, an increase of 44.79%. There were 415,117,372 shares traded in the last session compared with 98,568,509 shares during the previous 30 days. Moreover, the most recent 52-week price range for the stock was from $0.0013 to$0.105.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

So, what was behind this rush…


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


On the last day of the troublesome year 2020, In a preclinical study, Creative Medical Technology Holdings Inc. recently reported positive results using ImmCelz to treat a model of a heart attack.

Read More

Ex Vivo reprogrammed immune cells are used as a treatment for heart failure and post-infarct pathological remodeling of mice with restricted blood flow, which will significantly improve survival compared to controls.

Amit Patel, CEO of the company and co-inventor of a patent on the immune system, said that it is “no exaggeration” that the immune system is involved in numerous different aspects of regenerative medicine. “Today’s preliminary results support the notion that a “regenerative immunotherapy” referred to as ImmCelz could be used across a broad spectrum of conditions.”

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Drs Thomas Ichim and Amit Patel have spent decades of work developing the ImmCelz product. It involves the extraction of patient immune cells, incubation with regenerative cells outside of the body, and reinfusion of the patient’s cells. Its results to date have demonstrated the effectiveness of ImmCelz for the treatment of strokes and liver failure.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Flora Growth Corp. (FLGC) stock declines during premarket. Here’s what you should know?

Flora Growth Corp. (NASDAQ: FLGC) stock gained by 49.67% at last close whereas the FLGC stock price plunged by 18.36% in the pre-market trading...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Tonix Pharmaceutics Holdings Inc. (TNXP) stock gains during current market. What’s driving it high?

Tonix Pharmaceuticals Holdings Inc. (TNXP) stock gains by 2.81% in the current market trading session. Tonix is a clinical-stage biopharmaceutical business dedicated on finding,...

Intec Pharma Inc. (NTEC) stock declines during current market after a massive upraise. What’s happening?

Intec Pharma Inc. (NASDAQ: NTEC) stock drops by 7.88% during the current market trading session. Intec Pharma is a clinical-stage biopharmaceutical firm specializing in...

Related News

Tonix Pharmaceutics Holdings Inc. (TNXP) stock gains during current market. What’s driving it high?

Tonix Pharmaceuticals Holdings Inc. (TNXP) stock gains by 2.81% in the current market trading session. Tonix is a clinical-stage biopharmaceutical business dedicated on finding,...

NanoVibronix Inc. (NAOV) stock fell during after-market. Let’s find out why?

NanoVibronix Inc. (NAOV) stock plunged by 27.2% at the last close while the NAOV stock price fell by 8.42% in the after-hours trading session....

China Online Education Group Inc. (COE) stock fell during current market. Here’s the update

China Online Education Group Inc. (COE) stock declines by 13.91% in the current market trading. China Online Education Group is a major Chinese online...

Abeona Therapeutics Inc. (ABEO) stock surged during current market trading. Why so?

Abeona Therapeutics Inc. (ABEO) stock gains by 6.63% in the current market trading session. Abeona Therapeutics Inc. is a pharmaceutical firm in the early...

17 Education & Technology Group Inc. (YQ) stock plummeting continues on Monday pre-market but why?

17 Education & Technology Group Inc. (YQ) stock has declined 21.28% as of this writing in Monday,s pre-market. In the regular trading session on...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam